Li Y - Search Results

1

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models.

Li Y, Wang M, Zhi P, You J, Gao JQ. Li Y, et al. Oncotarget. 2017 Dec 8;9(2):2158-2174. doi: 10.18632/oncotarget.23187. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416762 Free PMC article.

2

Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment.

Li Y, Luo J, Lin MT, Zhi P, Guo WW, Han M, You J, Gao JQ. Li Y, et al. Mol Pharm. 2019 Jul 1;16(7):2966-2979. doi: 10.1021/acs.molpharmaceut.9b00199. Epub 2019 May 30. Mol Pharm. 2019. PMID: 31095914

3

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery.

Li Y, Wang M, Huang BW, Ping Y, You J, Gao JQ. Li Y, et al. Int J Nanomedicine. 2017 Nov 29;12:8557-8572. doi: 10.2147/IJN.S148975. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29238192 Free PMC article.

4

A tumor targeted near-infrared light-controlled nanocomposite to combat with multidrug resistance of cancer.

Wang M, Wu J, Li Y, Li F, Hu X, Wang G, Han M, Ling D, Gao J. Wang M, et al. Among authors: li f, li y. J Control Release. 2018 Oct 28;288:34-44. doi: 10.1016/j.jconrel.2018.08.037. Epub 2018 Aug 29. J Control Release. 2018. PMID: 30171977

5

Reactive oxygen species and near-infrared light dual-responsive indocyanine green-loaded nanohybrids for overcoming tumour multidrug resistance.

Wang M, Xiao Y, Li Y, Wu J, Li F, Ling D, Gao J. Wang M, et al. Among authors: li f, li y. Eur J Pharm Sci. 2019 Jun 15;134:185-193. doi: 10.1016/j.ejps.2019.04.021. Epub 2019 Apr 23. Eur J Pharm Sci. 2019. PMID: 31026507

6

Chemosensitization of doxorubicin in multidrug-resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis.

Wang M, Han M, Li Y, Jin Y, Gao JQ. Wang M, et al. Among authors: li y. J Pharm Pharmacol. 2016 Mar;68(3):333-41. doi: 10.1111/jphp.12528. Epub 2016 Feb 19. J Pharm Pharmacol. 2016. PMID: 26893058

7

Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.

Wang M, Li Y, HuangFu M, Xiao Y, Zhang T, Han M, Xu D, Li F, Ling D, Jin Y, Gao J. Wang M, et al. Among authors: li f, li y. Nanomedicine (Lond). 2016 Nov;11(22):2917-2934. doi: 10.2217/nnm-2016-0252. Epub 2016 Oct 26. Nanomedicine (Lond). 2016. PMID: 27780403

8

Chitosan nanoparticles and their Tween 80 modified counterparts disrupt the developmental profile of zebrafish embryos.

Yuan Z, Li Y, Hu Y, You J, Higashisaka K, Nagano K, Tsutsumi Y, Gao J. Yuan Z, et al. Among authors: li y. Int J Pharm. 2016 Dec 30;515(1-2):644-656. doi: 10.1016/j.ijpharm.2016.10.071. Epub 2016 Nov 5. Int J Pharm. 2016. PMID: 27826026

9

Co-delivery of deferoxamine and hydroxysafflor yellow A to accelerate diabetic wound healing via enhanced angiogenesis.

Gao SQ, Chang C, Li JJ, Li Y, Niu XQ, Zhang DP, Li LJ, Gao JQ. Gao SQ, et al. Among authors: li jj, li lj, li y. Drug Deliv. 2018 Nov;25(1):1779-1789. doi: 10.1080/10717544.2018.1513608. Drug Deliv. 2018. PMID: 30338719 Free PMC article.

10

Uniformly sized iron oxide nanoparticles for efficient gene delivery to mesenchymal stem cells.

Xu Q, Zhang T, Wang Q, Jiang X, Li A, Li Y, Huang T, Li F, Hu Y, Ling D, Gao J. Xu Q, et al. Among authors: li f, li y, li a. Int J Pharm. 2018 Dec 1;552(1-2):443-452. doi: 10.1016/j.ijpharm.2018.10.023. Epub 2018 Oct 9. Int J Pharm. 2018. PMID: 30312747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241,777 results

Search Page

Filters